Köksal Yavuz, Calişkan Umran, Uçar Canan, Erekul Selim, Ilerisoy Yakut Zeynep
Department of Pediatrics, Selçuk University Meram Faculty of Medicine, Konya, Turkey.
Turk J Pediatr. 2006 Oct-Dec;48(4):354-6.
Autoimmune hemolytic anemia (AIHA) is an unusual complication of malignancy. We diagnosed primary splenic anaplastic large cell lymphoma (ALCL) in a patient. A seven-year-old boy presented with Coombs test-positive hemolytic anemia. After a course of prednisolone therapy, a complete response for anemia was achieved. Twenty months later, in addition to severe hemolytic anemia, the patient was diagnosed with ALCL after splenectomy and pathologic examination of the sample. The recognition of this clinical picture as a complication of non-Hodgkin's lymphoma has important implications. The most effective management of AIHA in the setting of cancer is to treat the underlying malignancy.
自身免疫性溶血性贫血(AIHA)是恶性肿瘤的一种罕见并发症。我们诊断出一名原发性脾间变性大细胞淋巴瘤(ALCL)患者。一名7岁男孩出现库姆斯试验阳性的溶血性贫血。经过一个疗程的泼尼松龙治疗,贫血得到完全缓解。20个月后,除了严重的溶血性贫血外,患者在脾切除术后经样本病理检查被诊断为ALCL。认识到这种临床情况是一种非霍奇金淋巴瘤的并发症具有重要意义。在癌症背景下,AIHA最有效的治疗方法是治疗潜在的恶性肿瘤。